Free Trial

Tarsus Pharmaceuticals (TARS) Insider Trading & Ownership

Tarsus Pharmaceuticals logo
$54.41 +1.50 (+2.84%)
(As of 05:45 PM ET)

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.25%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$911,337.60
Get TARS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tarsus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TARS Insider Buying and Selling by Quarter

Tarsus Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/18/2024Aziz MottiwalaInsiderSell4,766$30.60$145,839.60  
3/18/2024Bobak R AzamianCEOSell10,415$30.60$318,699.00  
3/18/2024Bryan WahlGeneral CounselSell4,436$30.60$135,741.60  
3/18/2024Seshadri NeervannanCOOSell4,879$30.60$149,297.40  
12/27/2023Bobak R AzamianCEOSell8,000$20.22$161,760.00  
(Data available from 1/1/2013 forward)

TARS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Tarsus Pharmaceuticals includes Andrew D Goldberg, Aziz Mottiwala, Bobak R Azamian, Bryan Wahl, Dianne C Whitfield, Elizabeth Yeu Lin, Jose M Trevejo, Leonard M Greenstein, Mark J Holdbrook, Michael Ackermann, Seshadri Neervannan, and Vivo Capital Ix, Llc. Learn more on insiders at TARS.

8.25% of Tarsus Pharmaceuticals stock is owned by insiders. Learn more on TARS's insider holdings.

The following insiders have purchased TARS shares in the last 24 months: Andrew D Goldberg ($18,960.00), and Elizabeth Yeu Lin ($159,700.80).

Insiders have purchased a total of 10,506 TARS shares in the last 24 months for a total of $178,660.80 bought.

The following insiders have sold TARS shares in the last 24 months: Aziz Mottiwala ($235,840.83), Bobak R Azamian ($5,480,677.99), Bryan Wahl ($285,568.12), Dianne C Whitfield ($140,473.64), Jose M Trevejo ($87,281.86), Leonard M Greenstein ($222,702.33), Mark J Holdbrook ($5,008.19), and Seshadri Neervannan ($163,674.27).

Insiders have sold a total of 354,276 Tarsus Pharmaceuticals shares in the last 24 months for a total of $6,621,227.23 sold.

Tarsus Pharmaceuticals Key Executives

  • Dr. Bobak R. Azamian M.D.
    Co-Founder, President, CEO & Chairman
  • Mr. Jeffrey S. Farrow (Age 62)
    CFO & Chief Strategy Officer
    Compensation: $722.95k
  • Dr. Seshadri Neervannan Ph.D. (Age 56)
    Chief Operating Officer
    Compensation: $759.2k
  • Dr. Elizabeth Yeu Lin M.D. (Age 46)
    Chief Medical Advisor & Director
    Compensation: $59.12k
  • Mr. David Nakasone
    Head of Investor Relations
  • Dr. Bryan Wahl J.D. (Age 46)
    M.D., General Counsel & Corporate Secretary
    Compensation: $619.09k
  • Ms. Adrienne Kemp
    Senior Director of Corporate Communications
  • Mr. Matthew Rossen M.B.A. (Age 46)
    Vice President of Marketing
  • Mr. Scott Youmans
    Vice President of Sales
  • Ms. Dianne C. Whitfield M.S.W. (Age 47)
    Chief Human Resources Officer
    Compensation: $578.9k


This page (NASDAQ:TARS) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners